273 related articles for article (PubMed ID: 32814053)
21. Integration of multiple biological features yields high confidence human protein interactome.
Karagoz K; Sevimoglu T; Arga KY
J Theor Biol; 2016 Aug; 403():85-96. PubMed ID: 27196966
[TBL] [Abstract][Full Text] [Related]
22. Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases.
Longhena F; Spano P; Bellucci A
Handb Exp Pharmacol; 2018; 245():85-110. PubMed ID: 28965171
[TBL] [Abstract][Full Text] [Related]
23. Phase Separation and Neurodegenerative Diseases: A Disturbance in the Force.
Zbinden A; Pérez-Berlanga M; De Rossi P; Polymenidou M
Dev Cell; 2020 Oct; 55(1):45-68. PubMed ID: 33049211
[TBL] [Abstract][Full Text] [Related]
24. Nanoscale Analysis Reveals the Maturation of Neurodegeneration-Associated Protein Aggregates: Grown in mRNA Granules then Released by Stress Granule Proteins.
Abrakhi S; Kretov DA; Desforges B; Dobra I; Bouhss A; Pastré D; Hamon L
ACS Nano; 2017 Jul; 11(7):7189-7200. PubMed ID: 28657719
[TBL] [Abstract][Full Text] [Related]
25. Cross-linking Mass Spectrometry Analysis of the Yeast Nucleus Reveals Extensive Protein-Protein Interactions Not Detected by Systematic Two-Hybrid or Affinity Purification-Mass Spectrometry.
Bartolec TK; Smith DL; Pang CNI; Xu YD; Hamey JJ; Wilkins MR
Anal Chem; 2020 Jan; 92(2):1874-1882. PubMed ID: 31851481
[No Abstract] [Full Text] [Related]
26. Proteins in aggregates functionally impact multiple neurodegenerative disease models by forming proteasome-blocking complexes.
Ayyadevara S; Balasubramaniam M; Gao Y; Yu LR; Alla R; Shmookler Reis R
Aging Cell; 2015 Feb; 14(1):35-48. PubMed ID: 25510159
[TBL] [Abstract][Full Text] [Related]
27. The Antiaggregative and Antiamyloidogenic Properties of Nanoparticles: A Promising Tool for the Treatment and Diagnostics of Neurodegenerative Diseases.
Pichla M; Bartosz G; Sadowska-Bartosz I
Oxid Med Cell Longev; 2020; 2020():3534570. PubMed ID: 33123310
[TBL] [Abstract][Full Text] [Related]
28. A homologous mapping method for three-dimensional reconstruction of protein networks reveals disease-associated mutations.
Huang SH; Lo YS; Luo YC; Tseng YY; Yang JM
BMC Syst Biol; 2018 Mar; 12(Suppl 2):13. PubMed ID: 29560828
[TBL] [Abstract][Full Text] [Related]
29. Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation.
Rokad D; Ghaisas S; Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Brain Res Bull; 2017 Jul; 133():60-70. PubMed ID: 27993598
[TBL] [Abstract][Full Text] [Related]
30. Prion-like properties of assembled TDP-43.
Nonaka T; Hasegawa M
Curr Opin Neurobiol; 2020 Apr; 61():23-28. PubMed ID: 31862626
[TBL] [Abstract][Full Text] [Related]
31. Expedition into Taurine Biology: Structural Insights and Therapeutic Perspective of Taurine in Neurodegenerative Diseases.
Bhat MA; Ahmad K; Khan MSA; Bhat MA; Almatroudi A; Rahman S; Jan AT
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32516961
[TBL] [Abstract][Full Text] [Related]
32. Domain-based prediction of the human isoform interactome provides insights into the functional impact of alternative splicing.
Ghadie MA; Lambourne L; Vidal M; Xia Y
PLoS Comput Biol; 2017 Aug; 13(8):e1005717. PubMed ID: 28846689
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms of the co-deposition of multiple pathological proteins in neurodegenerative diseases.
Nonaka T; Masuda-Suzukake M; Hasegawa M
Neuropathology; 2018 Feb; 38(1):64-71. PubMed ID: 28948653
[TBL] [Abstract][Full Text] [Related]
34. Microbial Genetic Screens for Monitoring Protein Misfolding Associated with Neurodegeneration: Tools for Identifying Disease-Relevant Genes and for Screening Synthetic and Natural Compound Libraries for the Discovery of Potential Therapeutics.
Kostelidou K; Matis I; Skretas G
Curr Pharm Des; 2018; 24(19):2055-2075. PubMed ID: 29766788
[TBL] [Abstract][Full Text] [Related]
35. The commonality of protein interaction networks determined in neurodegenerative disorders (NDDs).
Limviphuvadh V; Tanaka S; Goto S; Ueda K; Kanehisa M
Bioinformatics; 2007 Aug; 23(16):2129-38. PubMed ID: 17553855
[TBL] [Abstract][Full Text] [Related]
36. Why do essential proteins tend to be clustered in the yeast interactome network?
Lu C; Hu X; Wang G; Leach LJ; Yang S; Kearsey MJ; Luo ZW
Mol Biosyst; 2010 May; 6(5):871-7. PubMed ID: 20567773
[TBL] [Abstract][Full Text] [Related]
37. Protein-protein interactions: network analysis and applications in drug discovery.
Bultinck J; Lievens S; Tavernier J
Curr Pharm Des; 2012; 18(30):4619-29. PubMed ID: 22650261
[TBL] [Abstract][Full Text] [Related]
38. Strategies towards high-quality binary protein interactome maps.
Lemmens I; Lievens S; Tavernier J
J Proteomics; 2010 Jun; 73(8):1415-20. PubMed ID: 20153845
[TBL] [Abstract][Full Text] [Related]
39. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.
Lim J; Hao T; Shaw C; Patel AJ; Szabó G; Rual JF; Fisk CJ; Li N; Smolyar A; Hill DE; Barabási AL; Vidal M; Zoghbi HY
Cell; 2006 May; 125(4):801-14. PubMed ID: 16713569
[TBL] [Abstract][Full Text] [Related]
40. TDP-43 suppresses tau expression via promoting its mRNA instability.
Gu J; Wu F; Xu W; Shi J; Hu W; Jin N; Qian W; Wang X; Iqbal K; Gong CX; Liu F
Nucleic Acids Res; 2017 Jun; 45(10):6177-6193. PubMed ID: 28335005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
